This page shows the latest PRIME designation news and features for those working in and with pharma, biotech and healthcare.
Swiss pharma company Novartis has received a breakthrough therapy designation (BTD) for its experimental medication iptacopan for the rare blood disorder paroxysmal nocturnal hemoglobinuria (PNH). ... The European Medicines Agency (EMA) has also granted
Gene therapy has been given a PRIME designation. Biotech company bluebird bio has been awarded a priority medicines (PRIME) designation by the European Medicines Agency (EMA) for its gene therapy LentiGlobin ... The PRIME designation shows the importance
Following the acceptance of the application and priority review designation, the FDA has set a Prescription Drug User Fee Act (PDUFA) date of 27 March 2021, setting up a potential launch ... Ide-cel has been awarded a Priority Medicines (PRIME)
The ADC has been given a breakthrough designation by the FDA as well as PRIME designation from the EMA in Europe.
data. A PRIME designation gives medicines priority and provides them with special support – this includes enhanced interaction and dialogue, and an accelerated evaluation and review. ... We are very pleased the EMA recognises the transformative
This was thanks to the EMA’s PRIME designation, a fast-track appraisal system particularly focused on cutting edge therapies from smaller-to-medium sized pharma and biotech firms.
More from news
Approximately 2 fully matching, plus 13 partially matching documents found.
The 11 drugs identified collectively hold 18 orphan drug designations, four FDA breakthrough therapy designations, two EU PRIME designations and one Japanese SAKIGAKE designation.
Bluebird says its decision to file in Europe first was in part thanks to LentiGlobin being accepted on to the EMA’s PRIME fast track designation, which allows early discussions about ... Upadacitinib is already in a phase 3 trial in atopic dermatitis
Going for scientific advice once given the PRIME designation can also mean faster advice: a 40-day timeframe versus the 70-day standard. ... SMEs can also get a filing fee reduction. PRIME numbers after 2 years.
There is no question that these products are truly groundbreaking: three have FDA Breakthrough Therapy Designation and two have the similar PRIME designation from the EMA. ... European regulator giving the therapy its PRIME designation in September 2016.
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...